Provided by Tiger Trade Technology Pte. Ltd.

Collegium Pharmaceutical

22.09
-0.0200-0.09%
Post-market: 21.27-0.8200-3.71%18:43 EDT
Volume:438.44K
Turnover:9.73M
Market Cap:719.15M
PE:17.39
High:22.40
Open:22.01
Low:21.77
Close:22.11
52wk High:50.79
52wk Low:21.43
Shares:32.56M
Float Shares:31.37M
Volume Ratio:0.61
T/O Rate:1.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.73
ROE:17.61%
ROA:5.75%
PB:2.31
PE(LYR):12.77

Loading ...

Collegium Pharmaceutical Updates Guidance After AZSTARYS Acquisition

TIPRANKS
·
Aug 06

GUIDANCE: (COLL) Collegium Pharmaceutical Expects 2026 Net Product Revenue Range $825M to $855M

MT Newswires Live
·
Aug 06

Collegium Turns to GAAP Net Loss of $15.1 Million in Q2 FY26; Revenue Rises 6% to $199.9 Million

Reuters
·
Aug 06

Collegium Pharmaceutical Q2 Adj. EPS $1.92 Beats $1.72 Estimate, Sales $199.878M Miss $201.206M Estimate

Benzinga Earnings
·
Aug 06

Collegium Pharmaceutical Q2 Adjusted EPS USD 1.92 VS. Ibes Estimate USD 1.72

THOMSON REUTERS
·
Aug 06

Collegium Pharmaceutical Outlook FY Adjusted Ebitda USD 445-470 Million

THOMSON REUTERS
·
Aug 06

Collegium Pharmaceutical Outlook FY Revenue USD 825-855 Million

THOMSON REUTERS
·
Aug 06

How Collegium's Quarterly Beat but Softer Outlook Could Reframe Collegium Pharmaceutical (COLL) Investors

Simply Wall St.
·
Jul 29

Collegium Pharmaceutical to Report Q2 2026 Results, Host Earnings Call

Reuters
·
Jul 23

Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston

GlobeNewswire
·
Jul 20

Engene Names Michael Heffernan Board Chairman as Richard Glickman Steps Down

Reuters
·
Jul 16

Is Collegium Pharmaceutical (COLL) A Bargain On Its Azstarys Deal And 2026 Guidance?

Simply Wall St.
·
Jul 04

Collegium Amends 8-K to Add Corium Therapeutics Audited Financial Statements

Reuters
·
Jul 01

Did Collegium Pharmaceutical’s Profitability Surge and Efficiency Gains Just Shift COLL’s Investment Narrative?

Simply Wall St.
·
Jun 21

Collegium Pharmaceutical awards 50,305 RSUs to 34 newly hired employees under inducement plan

Reuters
·
Jun 05

Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 05

Collegium Pharma director John Gordon Freund sells 20 shares for $681

Reuters
·
May 21

Collegium director John Gordon Freund disposes 4,127 shares for $142,557.58

Reuters
·
May 19

Collegium Pharma director Michael Donovan files initial beneficial ownership statement

Reuters
·
May 19

Collegium Pharmaceutical shareholders elect eight directors at annual meeting

Reuters
·
May 16